STAT14h
Sanofi is warned by the FDA over ‘significant’ problems at a key manufacturing plant
The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...
ENDPOINTS NEWS16h
Sanofi says no sup­ply in­ter­rup­tions af­ter land­ing FDA warn­ing let­ter for US site
A new FDA warning letter for French pharmaceutical company Sanofi cited a handful of issues at its biologics factory in ...
FiercePharma17h
Sanofi API plant hit with FDA warning letter detailing quality, consistency flubs
Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a ...
FiercePharma18h
Sanofi's consumer health arm Opella secures FDA green light to pursue OTC Cialis study
After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...
Hosted on MSN21h
Denali Gains 26.6% in a Year: How Should You Play the Stock?
Denali Therapeutics DNLI has performed well in the past 12 months amid a volatile market. Shares of the company have gained ...
Sanofi says FDA lifted clinical hold on trial for Cialis OTC switch
Sanofi’s (SNY) said FDA lifted a hold on a trial to test over-the-counter use of its Eli-Lilly (LLY)-partnered erectile ...
The Pharma Letter23h
Sanofi reaches study milestone for Cialis
French pharma major Sanofi’s consumer healthcare business, Opella, has announced that the US Food and Drug Administration ...
AI can call the shots on drug making because it 'doesn't have a career at stake,' major pharma CEO says
"And we're not used to having somebody without a career at stake in the room at a senior level," said Hudson.